[Increase of factor VIII-(antihemophilic globulin)-activity in plasma of hemophiliacs following addition of synthetic fibrinolytic compounds].
D000838:Anions; D002245:Carbon Dioxide / Q000494:pharmacology; D005169:Factor VIII / Q000378:metabolism*; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D005439:Flufenamic Acid / Q000494:pharmacology; D006467:Hemophilia A / Q000097:blood*; D006801:Humans; D066298:In Vitro Techniques; D012459:Salicylates / Q000494:pharmacology; D013876:Thiophenes / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D000838:Anions; D005343:Fibrinolytic Agents; D012459:Salicylates; D013876:Thiophenes; D062367:ortho-Aminobenzoates; D002245:Carbon Dioxide; D005439:Flufenamic Acid; D005169:Factor VIII
Ansteigen von Faktor viii-(Antihämophiles Globulin)-Aktivität im Plasma von Hämophilen nach Zusatz synthetischer fibrinolytischer Verbindungen.